|
⚲
|
| Keyboard |
| Ali Asif
✚
|
|
|---|---|
| CIK # | 0001921163 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001921163] | |
| 4 | [0001921163] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Ali Asif | |
| Protagonist Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-03-26 | Option exercise | 19,500 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-03-26 | Option exercise | 5,265 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-03-26 | Option exercise | 19,500 | $19.19 | 374,205 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-03-26 | Option exercise | 5,265 | $12.17 | 64,075 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-03-26 | Sell | 24,765 | $104.24 | 2,581,504 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-27 | Option exercise | 16,000 | $19.19 | 307,040 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-27 | Option exercise | 12,000 | $12.17 | 146,040 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-27 | Option exercise | 12,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-27 | Option exercise | 16,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-27 | Sell | 18,203 | $83.14 | 1,513,397 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-27 | Sell | 28,000 | $83.13 | 2,327,640 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-20 | Sell | 8,588 | $82.48 | 708,338 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2026-01-02 | Grant | 25,600 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2026-01-02 | Grant | 32,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-04-22 | Sell | 1,756 | $46.00 | 80,776 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-03-12 | Option exercise | 9,700 | $19.19 | 186,143 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-03-12 | Option exercise | 9,700 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2025-03-12 | Option exercise | 15,203 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-03-12 | Sell | 24,903 | $58.73 | 1,462,553 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2025-03-12 | Option exercise | 15,203 | $12.17 | 185,021 |
| showing 20 of 47 most recent transactions | |||||